SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
Author(s) -
Prerna Arora,
Amy Kempf,
Inga Nehlmeier,
Luise Graichen,
Martin Sebastian Winkler,
Martin Lier,
Sebastian Schulz,
HansMartin Jäck,
Anne Cossmann,
Metodi V. Stankov,
Georg M. N. Behrens,
Stefan Pöhlmann,
Markus Hoffmann
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110754
Subject(s) - neutralization , antibody , virology , spike protein , vaccination , biology , covid-19 , immune escape , immunology , immune system , medicine , infectious disease (medical specialty) , disease , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom